MUFG Securities EMEA plc boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 42,297.6% during the 4th quarter, Holdings Channel reports. The fund owned 300,175 shares of the company’s stock after acquiring an additional 299,467 shares during the quarter. Johnson & Johnson makes up 2.8% of MUFG Securities EMEA plc’s portfolio, making […]
Analyst IMS Investment Management Services Ltd. boosted its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 5.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,650 shares of the company’s stock after purchasing an additional 84 shares during the quarter. Analyst IMS […]
Act Two Investors LLC bought a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 11,790 shares of the company’s stock, valued at approximately $1,848,000. Johnson & Johnson makes up about 0.4% of Act […]
Act Two Investors LLC purchased a new stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 11,790 shares of the company’s stock, valued at approximately $1,848,000. Johnson & Johnson comprises […]
Princeton Capital Management LLC reduced its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 13.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,660 shares of the biopharmaceutical company’s stock after selling 1,172 shares during the period. Princeton Capital Management […]